Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junqi Niu

Showing results (141-150 of 280) with videos related to

Pageof 28
Sort By:
Yonsei Medical Journal|April 4, 2015
IL28B is associated with outcomes of chronic HBV infectionXiaodong Shi, Xiumei Chi, Yu Pan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2015
CD24 Ala57Val polymorphism is associated with spontaneous viral clearance in the HCV-infected Chinese populationHaibo Sun, Yu Pan, Ruihong Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2020
Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV InfectionHong Zhang, Fengjiao Wang, Xiaoxue Zhu, et al.
Frontiers in Microbiology|March 2, 2026
Assessment of self-reported prevalence, vaccination status, knowledge and behavioral determinants of hepatitis B and D in Pakistan: a cross-sectional studySajid Ur Rahman, Yanfei Gao, Fazal Noor, et al.
Science China. Life Sciences|September 30, 2024
Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis BLian Liu, Danyan Zhang, Rong Fan, et al.
Journal of Virology|January 11, 2019
RNA-Binding Motif Protein 24 (RBM24) Is Involved in Pregenomic RNA Packaging by Mediating Interaction between Hepatitis B Virus Polymerase and the Epsilon ElementYongxuan Yao, Bo Yang, Yingshan Chen, et al.
Antiviral Research|December 16, 2019
Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infectionHong Zhang, Min Wu, Xiaoxue Zhu, et al.
The Journal of General Virology|June 16, 2016
IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18Weiguo Fan, Shiqi Xie, Xinhao Zhao, et al.
Frontiers in Pharmacology|December 9, 2021
HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's DiseaseYixiao Zhi, Yujiao Sun, Yonggeng Jiao, et al.
The Journal of Infectious Diseases|May 11, 2019
A Nanoparticle-Based Hepatitis C Virus Vaccine With Enhanced PotencyYu Yan, Xuesong Wang, Peilan Lou, et al.
Pageof 28

Showing results (141-150 of 280) with videos related to

Sort By:
Pageof 28
Yonsei Medical Journal|April 4, 2015
IL28B is associated with outcomes of chronic HBV infectionXiaodong Shi, Xiumei Chi, Yu Pan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 16, 2015
CD24 Ala57Val polymorphism is associated with spontaneous viral clearance in the HCV-infected Chinese populationHaibo Sun, Yu Pan, Ruihong Wu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 11, 2020
Antiviral Activity and Pharmacokinetics of the Hepatitis B Virus (HBV) Capsid Assembly Modulator GLS4 in Patients With Chronic HBV InfectionHong Zhang, Fengjiao Wang, Xiaoxue Zhu, et al.
Frontiers in Microbiology|March 2, 2026
Assessment of self-reported prevalence, vaccination status, knowledge and behavioral determinants of hepatitis B and D in Pakistan: a cross-sectional studySajid Ur Rahman, Yanfei Gao, Fazal Noor, et al.
Science China. Life Sciences|September 30, 2024
Serum ECM1 is a promising biomarker for staging and monitoring fibrosis in patients with chronic hepatitis BLian Liu, Danyan Zhang, Rong Fan, et al.
Journal of Virology|January 11, 2019
RNA-Binding Motif Protein 24 (RBM24) Is Involved in Pregenomic RNA Packaging by Mediating Interaction between Hepatitis B Virus Polymerase and the Epsilon ElementYongxuan Yao, Bo Yang, Yingshan Chen, et al.
Antiviral Research|December 16, 2019
Safety, efficacy, and pharmacokinetics of pradefovir for the treatment of chronic hepatitis B infectionHong Zhang, Min Wu, Xiaoxue Zhu, et al.
The Journal of General Virology|June 16, 2016
IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18Weiguo Fan, Shiqi Xie, Xinhao Zhao, et al.
Frontiers in Pharmacology|December 9, 2021
HR-MS Based Untargeted Lipidomics Reveals Characteristic Lipid Signatures of Wilson's DiseaseYixiao Zhi, Yujiao Sun, Yonggeng Jiao, et al.
The Journal of Infectious Diseases|May 11, 2019
A Nanoparticle-Based Hepatitis C Virus Vaccine With Enhanced PotencyYu Yan, Xuesong Wang, Peilan Lou, et al.
Pageof 28